GlassScriptPhysician profile
Satish N Patel
NPI 1578728549
$15,889.66
in general payments reported to CMS, 2019-2025
44 companies · $4,253 in 2025
The $4,253 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,018 · 2020: $1,765 · 2021: $2,029 · 2022: $2,070 · 2023: $1,341 · 2024: $3,414 · 2025: $4,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,007.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,095.05 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $2,074.63 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,683.93 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Glaxosmithkline, LLC. | $920.06 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $908.90 | 2020-2025 | Ozempic, Rybelsus, Tresiba |
| Pfizer INC. | $825.94 | 2020-2025 | |
| Corcept Therapeutics | $780.53 | 2024-2025 | Korlym |
| Esperion Therapeutics, INC. | $761.17 | 2020-2025 | Nexletol |
| Amgen INC. | $756.82 | 2020-2025 | Repatha, Evenity, Repatha |
| Sanofi-Aventis U.S. LLC | $706.63 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $591.69 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $420.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $289.10 | 2019-2025 | |
| Shield Therapeutics INC | $280.50 | 2023-2025 | |
| Exact Sciences Corporation | $219.75 | 2023-2025 | Cologuard Collection Kit |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.